NCT05494034 Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.
| NCT ID | NCT05494034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National and Kapodistrian University of Athens |
| Condition | Stroke, Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-05-05 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-05-05 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this prospective cohort study, the investigators aim to investigate the incidence of ICM-detected AF in unselected ischemic stroke patients and its association with anticoagulation initiation and stroke recurrence.
Eligibility Criteria
Inclusion Criteria: * Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled. * Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation \[brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan\]. * Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study. * Informed consent for participation in the study will be obtained from the patients or guardians of patients. Exclusion Criteria: * Patients with incomplete evaluation will be excluded, as previously described. \[22\] -Patients with known or newly detected AF at hospitalization will also be excluded. * Not providing informed consent.
Frequently Asked Questions
Who can join the NCT05494034 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 100 Years, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05494034 currently recruiting?
Yes, NCT05494034 is actively recruiting participants. Visit ClinicalTrials.gov or contact National and Kapodistrian University of Athens to inquire about joining.
Where is the NCT05494034 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT05494034 clinical trial?
NCT05494034 is sponsored by National and Kapodistrian University of Athens. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.